Meet the team

Diederik Stadig

Portrait of Diederik Stadig

Diederik Stadig

Senior Economist, Healthcare & Technology

Diederik Stadig is Healthcare and Technology economist at ING Research. He joined the firm in 2023 and previously worked as lecturer at de Vrije Universiteit Amsterdam. He holds a PhD in political economy from the same university.

diederik.stadig@ing.com

Latest from Diederik

AI monthly: Many still unconvinced of GenAI’s relevance

AI monthly: Many still unconvinced of GenAI’s relevance

Nearly two-thirds of EU internet users don’t use GenAI, citing 'no need'. Yet younger, educated heavy users worry most about job loss

China: the next Pfizer will be Chinese

Healthcare China

China: the next Pfizer will be Chinese

We believe that the next Pfizer will be Chinese

China’s spectacular rise reshapes Asia’s pharma future

Healthcare China

China’s spectacular rise reshapes Asia’s pharma future

The balance of power in the global pharmaceutical industry is shifting east

South Korea: Asia’s second innovation engine

Healthcare South Korea

South Korea: Asia’s second innovation engine

South Korea has been the second most important contributor to the growth of Asian drug innovation

India: from generics giant to innovation powerhouse?

Healthcare India

India: from generics giant to innovation powerhouse?

India’s pharma growth has been built on low-cost generics, making it the world’s 11th-largest market by value

Japan: Asia's Europe?

Healthcare Japan

Japan: Asia's Europe?

Makary's successor faces tough task managing FDA amid budget cuts

Commodities, Food & Agri Healthcare United States

Makary's successor faces tough task managing FDA amid budget cuts

Trump's 100% pharma tariffs will have a limited effect on the sector

Trump's 100% pharma tariffs will have a limited effect on the sector

Meet the team

Meet the team

All our authors

Youtube video thumbnail

Watch: European pharma's fight to stay relevant

European pharma's fight to stay relevant

Webinar: Europe's housing markets in a volatile world

Webinar: Europe's housing markets in a volatile world

Transformative or overhyped? The impact of weight-loss drugs on European food demand

Commodities, Food & Agri Healthcare

Transformative or overhyped? The impact of weight-loss drugs on European food…

Europe’s last chance to revive its pharmaceutical innovation power

Europe’s last chance to revive its pharmaceutical innovation power

Pharma’s Godfather moment: pulled back into tariff uncertainty

Pharma’s Godfather moment: pulled back into tariff uncertainty

Listen: Pharma 2026 - higher prices, manufacturing migration, China's ascent

Listen: Pharma 2026 - higher prices, manufacturing migration, China's…

3 calls for EU sectors in 2026: Tech outperformance, manufacturing growth gaps, small consumer gains

Transport & Logistics Manufacturing, Construction and Retail TMT

3 calls for EU sectors in 2026: Tech outperformance, manufacturing growth…

ING THINK banner photo

Sign up now for our newsletter

Get ING's economic and financial analysis sent straight to your inbox.

Subscribe